Identifying and characterizing small-molecule inhibitors of protein-protein interactions is of high interest for drug discovery and for chemical genetics studies of biological pathways. Such efforts often start with high-throughput screening (HTS) of compound libraries using a variety of assays. Fluorescence polarization methods, for example, have been particularly successful for identification of inhibitors of protein-protein interactions. 1 Depending on the design of the assays, initial hits typically have equilibrium dissociation constants in the low micromolar range at best. To be considered serious drug candidates, the affinities of such weak hit compounds have to be improved, and structure-based medicinal chemistry efforts have been found particularly powerful.
For a structure-based optimization of hit compounds, it is important to know whether a compound binds in a single welldefined conformation or adopts two or multiple bound states of comparable energy (Figure 1 ). This is related to specific and nonspecific binding, respectively. However, nonspecific binding is often but not always used synonymously with nonsaturable binding, while the situation depicted at the bottom panel of Figure 1 applies to both saturable and nonsaturable binding. To pursue a rational structure-based optimization of screening hits, it is important to know the binding mode. Only if a compound binds in a single conformation will a meaningful structure of the complex be determined and used to rationally optimize the affinity; compounds exhibiting multiple binding modes should be avoided or modified to adopt a single binding mode. Here we present a simple approach to distinguish single-mode from multiple-mode binding and show examples for both situations with ligands to the protein Bcl-xL.
Binding of weak initial hits that have low micromolar dissociation constants typically leads to chemical shift changes and/or broadening of protein resonances in the binding site. For example, Figure  2 shows a ligand titration in the 1 H-13 C HSQC spectrum of the methyl region of a Bcl-xL sample that has been 13 C-labeled and -protonated at the methyl groups of Ile, Leu, and Val, but deuterated everywhere else using methods described previously. [2] [3] [4] Clearly, resonances that are most affected exhibit chemical shift changes and increasing line broadening, such as V91γ 1 (identified with a box in Figure 2 ). We wanted to know whether the line broadening is just due to dissociation kinetics on the intermediate exchange time scale or might also be caused by multiple binding modes.
A distinction of these two cases could be made based on the following consideration. If the line broadening is due to intermediate exchange of the dissociation, excess of ligand should cause all protein to be in a bound state, and all protein resonances should become sharper compared to the stoichiometric ratio. This would not be the case if the broadening were also due to multiple bound conformations because of inherent conformational exchange between different bound states. To further analyze this, we have simulated the spectrum of a protein proton for the two situations outlined in Figure 1 . The chemical shift change ∆ν between free and bound protein was set to 100 Hz; the line width of the protein resonance was set to 20 Hz, and K D values of 20 and 80 µM were assumed to match situations for two ligands studied experimentally (see below). Using a procedure described previously, 5 the spectrum was simulated for protein:ligand concentrations of 1:0, 1:0.1, 1:0.25, 1:0.5, ... 1:10. The dynamic exchange between different bound states was modeled assuming two bound conformations and using an exchange relaxation term, ∆R a , of 80 Hz. 6 The simulation for the absence of multiple conformations shows the resonance, indeed, sharpening up upon excess of ligand ( Figure 3, bottom) ; in contrast, if there is chemical exchange between different bound states, the line does not sharpen upon providing excess ligand (Figure 3, top) .
Indeed, both situations have been found experimentally multiple times in our studies of Bcl-xL ligand interactions. The top trace of Figure 4 shows a cross-section along the proton frequency of V91γ 1 † Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139. . 1 H-13 C HSQC spectrum of a 25 µM sample of Bcl-xL that is 13 C-labeled only at the methyl groups of Ile, Leu, and Val. 3, 4 Black: no ligand, red 25 µM, and blue 250 µM ligand. The ligand is a first-generation compound from the primary screen; KD ) 80µM (shown on the insert). The cross-peak of V91γ 1 is placed in a box and further analyzed with crosssections in Figures 3 and 4. in the 1 H-13 C HSQC of Bcl-xL at different ligand concentrations of a compound that was found to bind with an apparent K D (K D app ) of 80 µM, as measured with fluorescence spectroscopy. Clearly, as much as 10-fold excess of this first-generation compound does not lead to sharpening of the bound resonance, indicating that there is an exchange between two or more different bound states. However, a slightly modified compound that binds with a K D app of 20 µM (replacing the left-hand aromatic group shown in Figure 2 with a substituted amino(bicycloheptane)) shows a different behavior (Figure 4, bottom) . Here excess of ligand leads to sharpening of the bound resonance, which indicates that the compound binds in a single conformation.
Thus, line shape analysis in a simple titration with excess ligand can clarify whether a compound binds with a single or with multiple conformation(s). In our experience with Bcl-xL and translation initiation factors, small-molecule inhibitors of protein-protein interactions identified with high-throughput screening of compound libraries often cause broadening of protein resonances, and it is desirable to identify the cause. Line broadening is also commonly observed for protein-protein and protein-nucleic acid interactions, where distinguishing between single-and multiple-mode binding is very important.
The titration experiments described above are often difficult to perform since small-molecule inhibitors are typically not soluble at high concentrations, and thus the binding mode cannot easily be tested at excess ligand conditions. 7 The Bcl-xL inhibitors studied here, for example, are soluble to at most 250 µM. Thus, providing a 10-fold excess of compound means that the protein concentration has to be as low as 25 µM. Fortunately, modern cryogenic probes allow one to record spectra, as shown in Figure 2 , at such low concentrations and enable the elucidation of the binding mechanism. The use of 1 H-13 C HSQC spectra of methyl-labeled proteins is beneficial compared to 1 H-15 N labeling; besides providing a 3-fold higher signal intensity, the experiments can be performed in D 2 O, and methyl resonances appear to be less susceptible to line broadening compared to backbone amides. 8 The effect is probably most easily detectable as a gradual loss of peak intensities. The same procedures are applicable to characterize the interaction mode of proteins with other proteins or nucleic acids. 7 
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